Bempedoic Acid: From Guidelines to the Real World
Jakub Michal Zimodro, Ioanna Gouni-Berthold · 2026
Read Bempedoic Acid: From Guidelines to the Real World by Jakub Michal Zimodro, Ioanna Gouni-Berthold (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13620188.txt.
Description
Jakub Michal Zimodro and Ioanna Gouni-Berthold review bempedoic acid, a cholesterol-lowering drug, from trial evidence to daily practice. Their 2026 review starts from a gap: heart and vessel disease remains the top global killer, and high cholesterol is often poorly controlled. Many patients cannot tolerate statins or do not reach targets on them alone.
The review covers how the drug works in the body, then sums up clinical trials and real-world studies of its benefit and safety. It closes by comparing how current guidelines place the drug in care. The authors describe it as a generally safe and cost-effective option for high-risk patients who cannot or will not take statins. Early combination therapy, rather than statin alone, frames much of the discussion.
Catalog record
| CREATOR | Jakub Michal Zimodro, Ioanna Gouni-Berthold |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |